Tobramycin/dexamethasone

Tobramycin/dexamethasone
Combination of
Tobramycin Aminoglycoside antibiotic
Dexamethasone Glucocorticoid
Clinical data
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Ophthalmic
ATC code S01CA01 (WHO)
Legal status
Legal status
Identifiers
CAS Number 288392-57-4 N
DrugBank DB00684 YesY
ChemSpider 10123949 N
KEGG D00063 N
ChEBI CHEBI:28864 YesY
ChEMBL CHEMBL1747 YesY
 NYesY (what is this?)  (verify)

Tobramycin/dexamethasone (INNs, trade name Tobradex, Tobrason in Jordan[1]) is a prescription medication in the form of eye drops and eye ointment, marketed by Alcon. The active ingredients are tobramycin 0.3% (an antibiotic) and dexamethasone 0.1% (a corticosteroid). It is prescribed for a wide spectrum of bacterial eye infections. Tobradex can also be used to clear or contract styes that are also found in the eye. It is prescribed for the treatment of pink eye in combination with bacterial infections. Because it contains a steroid, careful use with gradual reduction of doses is required.

Contraindications

It is strongly contraindicated with herpetic and other viral eye infections. Other contraindications include fungal and mycobacterial infections because tobramycin is inactive against those, and the corticoid acts as an immunosuppressive agent, preventing the body's immune system from dealing with the infection. The drops are also contraindicated in patients with corneal lesions.[2][3]

Side effects

Similarly to other corticosteroid eye drops, side effects include hypersensitivity and, especially after long-term use, secondary eye infections, cataract (clouding of the eye lens) and increased intraocular pressure, leading to glaucoma. Consequently, the drug should not be applied longer than 24 days.[2][4][5]

Interactions

Anticholinergic eye drops potentiate the risk of increased intraocular pressure. Systemic aminoglycoside antibiotics increase toxicity for ears, nerves and kidney.[2]

References

  1. http://www.jfda.jo/
  2. 1 2 3 Haberfeld, H, ed. (2009). Austria-Codex (in German) (2009/2010 ed.). Vienna: Österreichischer Apothekerverlag. ISBN 3-85200-196-X.
  3. Tobradex Prescribing Information. Alcon.
  4. Ch. Faschinger (3 January 2011). Österreichische Apothekerzeitung (in German) (1/2011): 13. Missing or empty |title= (help)
  5. Dinnendahl, V; Fricke, U, eds. (2010). Arzneistoff-Profile (in German). 2 (23 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag. ISBN 978-3-7741-9846-3.
This article is issued from Wikipedia - version of the 11/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.